Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-18-000429
Filing Date
2018-06-18
Accepted
2018-06-18 10:10:05
Documents
2
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1540
2 uniqurepoa_61318.htm EX-24 5472
  Complete submission text file 0000904454-18-000429.txt   8352
Mailing Address 3000 KENT AVENUE; SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Meek David D. (Reporting) CIK: 0001555337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36294 | Film No.: 18903791

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations